Heterocyclic Building Blocks for Medicinal Applications
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 January 2023) | Viewed by 3103
Special Issue Editors
Interests: cancer therapy; anti-infective drugs; molecular mechanisms; drug synthesis; targeted therapies; bioactive heterocycle synthesis; docking and molecular modelling
Special Issues, Collections and Topics in MDPI journals
Interests: antibiotics discovery; anticancerous drugs discovery; medicinal chemistry; organic synthesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the twenty-first century, an extremely high percentage of all drugs used in therapy contain at least one heterocyclic structure, with heterocyclic compounds being a very large and varied family of molecular fragments used by chemists for organic synthesis. This is not only due to their structural diversity and chemical properties but also because their heterocyclic nuclei are constituents of natural products and play a key role in biological processes. High-quality heterocyclic building blocks are crucial to the biological activities of different molecules and ADMET properties, which eventually impact the success rate of drug discovery projects.
This Special Issue in Molecules aims to familiarize readers with the most modern trends in the field of heterocyclic building blocks with or for medicinal applications. We encourage authors to submit original research articles, review papers, and short communications regarding the design and synthesis of new heterocyclic structures starting from synthetic compounds or from isolated natural compounds, in which the final goal is to obtain compounds with various biological actions or to optimize existing biological properties. Potential topics include but are not limited to the keywords listed below.
Prof. Dr. Brindusa Tiperciuc
Prof. Dr. Ovidiu Oniga
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heterocyclic synthesis
- medicinal chemistry
- hit and lead
- docking and molecular modulations
- natural compounds optimization
- stereoselectivity
- hybrid heterocycles
- QSAR
- heterocyclic building blocks
